Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
In the last 90 days, Processa Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Processa Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 17 | 18 | +1 |
| Shares | 1.15M | 1.37M | +218.4K (+19.0%) |
| Value | $12.3M | $11.2M | −$1.07M (−8.7%) |
New holders (5)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 27,596 | $226.0K | 0.00% |
| State Street Corp | 16,600 | $136.0K | 0.00% |
| Vectors Research Management, LLC | 4,000 | $33.0K | 0.01% |
| Allworth Financial LP | 1,700 | $14.0K | 0.00% |
| UBS Group AG | 42 | $0 | 0.00% |
Sold out (4)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Commonwealth Equity Services, LLC | 10,550 | $115.0K |
| Tower Research Capital LLC (TRC) | 235 | $3.00K |
| Morgan Stanley | 86 | $1.00K |
| Bank of America Corp | 30 | $0 |